关于在复发/耐火环境中治疗多发性骨髓瘤的指南:沙特骨髓瘤工作组指南
Ayman Alhejazi1, Ghazi S Alotaibi2, Abdullah S Al Saleh3
1Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Clinical lymphoma, myeloma & leukemia
|June 7, 2025
概括
新的沙特骨髓瘤工作组指南为治疗复发性或耐火性多发性骨髓瘤提供了最新的建议. 这些指导方针旨在通过不断发展的治疗策略和支持措施来改善患者的护理和结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床实践指南 临床实践指南
背景情况:
- 多发性骨髓瘤治疗已经取得进展,但该疾病经常复发并变得难治,随着每次后续治疗线路的推移,患者的生存率都在下降.
- 现有的多发性骨髓瘤管理指南需要更新,以反映最近的治疗进化和沙特阿拉伯的特定医疗保健背景.
- 迫切需要明确,适应性建议来管理疾病的进展,并提供必要的支持性护理.
研究的目的:
- 建立针对沙特阿拉伯的针对复发性和/或耐火性多发性骨髓瘤管理的最新建议.
- 为患有多发性骨髓瘤的患者提供最佳支持性护理措施的指导.
- 支持临床专家识别和治疗多发性骨髓瘤进展的各种模式.
主要方法:
- 沙特骨髓瘤工作组制定基于共识的建议.
- 对多发性骨髓瘤的当前治疗选择和支持性护理策略的审查和综合.
- 国际最佳实践适应沙特阿拉伯医疗保健环境.
主要成果:
- 发布全面的指导方针,解决复发性/耐药性多发性骨髓瘤的管理.
- 包括对支持性护理干预措施的详细建议.
- 强调根据疾病模式及时适当调整治疗.
结论:
- 新的建议为沙特临床医生提供了管理复杂多发性骨髓瘤病例的基本指导.
- 预计更新的策略将改善患者的治疗结果,并优化医疗保健资源的利用率.
- 这些指导方针为沙特阿拉伯的患者和医疗保健支付人提供了明智的决策.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...